<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="88">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 08, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02493569</url>
  </required_header>
  <id_info>
    <org_study_id>KYLLSL-2015-153-01</org_study_id>
    <nct_id>NCT02493569</nct_id>
  </id_info>
  <brief_title>A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China</brief_title>
  <official_title>A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China (Based on Hospital)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to study the epidemic features and diagnosis of female breast
      cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival
      (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multicentric, retrospective clinical study based on the hospital. The target
      number of cases are X patients who are eligible for breast cancer after radical mastectomy.
      To collect the clinicopathological data and treatment data of the breast cancer patients and
      do the follow-up visit of all the patients who are included in the study.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2015</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Ecologic or Community, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Overall five-year survival for the female breast cancer patients</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Epidemiology breast cancer patients</arm_group_label>
    <description>Observe the features of clinical diagnosis and treatment for female breast cancer patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>The radical mastectomy of breast cancer</intervention_name>
    <description>The radical mastectomy of breast cancer could be used for the treatment of breast cancer during the observation.</description>
    <arm_group_label>Epidemiology breast cancer patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The female breast cancer patients in Shaanxi Province of China, those study population
        shoud be the hospitalized patients who are confirmed of the primary breast cancer
        histologically, moreover, the date of the inpatients are within the month we chosen and
        those inpatients should have been received or under receiving the relevant treatment
        including surgical treatment, chemotherapy and radiotherapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1.female patients; 2. The hospitalized patients who are confirmed of the primary
             breast cancer    histologically; 3. The date of the inpatients are within the month
             we chosen; 4. Patients who are within the month we chosen have been received or under
             receiving the relevant treatment including surgical treatment, chemotherapy and
             radiotherapy.

        Exclusion Criteria:

          -  1. Male breast cancer patients; 2.patients with breast cancer who are not under the
             chosen time; 3. Non hospitalized patients.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu Ren, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu Ren, MD,PhD</last_name>
    <phone>13700222161</phone>
    <email>renyyyyy@126.com</email>
  </overall_contact>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 7, 2015</lastchanged_date>
  <firstreceived_date>July 7, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast cancer, hospital, epidemiology, diagnosis, treatment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
